These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8287635)

  • 21. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].
    Guibert J; Kitzis MD; Brumpt I; Acar JF
    Pathol Biol (Paris); 1989 May; 37(5):406-10. PubMed ID: 2506514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers.
    Petitjean O; Pangon B; Brion N; Tod M; Chaplain C; Le Gros V; Louchahi K; Allouch P
    Antimicrob Agents Chemother; 1993 Apr; 37(4):737-40. PubMed ID: 8494368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections].
    Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J
    Therapie; 1990; 45(6):461-5. PubMed ID: 2080483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of trikatu pretreatment on the pharmacokinetics of pefloxacin administered orally in mountain Gaddi goats.
    Dama MS; Varshneya C; Dardi MS; Katoch VC
    J Vet Sci; 2008 Mar; 9(1):25-9. PubMed ID: 18296885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal penetration of oral pefloxacin in humans.
    Oncel M; Peyman GA
    Int Ophthalmol; 1993 Aug; 17(4):217-22. PubMed ID: 8112969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of pefloxacin in renal insufficiency.
    Montay G; Jacquot C; Bariety J; Cunci R
    Eur J Clin Pharmacol; 1985; 29(3):345-9. PubMed ID: 3865778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose pharmacokinetics of cetirizine in patients with chronic liver disease.
    Horsmans Y; Desager JP; Hulhoven R; Harvengt C
    J Clin Pharmacol; 1993 Oct; 33(10):929-32. PubMed ID: 8227463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study.
    Descombes E; Martins F; Hemett OM; Erard V; Chuard C
    BMC Pharmacol Toxicol; 2016 Feb; 17():4. PubMed ID: 26846675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute epididymitis and antibiotherapy. Measurement of the epididymal diffusion of pefloxacin].
    Costa P; Galtier M; Laurelli JM; Nivard G; Louis JF; Favier M; Hansel S; Navratil H; Grasset D
    J Urol (Paris); 1989; 95(1):41-4. PubMed ID: 2732484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decontamination of the bowel by intravenous administration of pefloxacin.
    Vollaard EJ; Clasener HA; Janssen AJ
    J Antimicrob Chemother; 1990 Dec; 26(6):847-52. PubMed ID: 2081723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis.
    Schmit JL; Hary L; Bou P; Renaud H; Westeel PF; Andrejak M; Fournier A
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1492-4. PubMed ID: 1929314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cimetidine in patients with liver disease.
    González-Martin G; Arancibia A; Fajuri M; Chesta J; Novoa X
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
    Khlebnikov EP; Vishnevskiĭ VA; Kubyshkin VA; Terekhova RP
    Antibiot Khimioter; 2009; 54(3-4):32-7. PubMed ID: 19711848
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of brodimoprim.
    Weidekamm E
    J Chemother; 1993 Dec; 5(6):475-9. PubMed ID: 8195840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of pefloxacin in normal and impaired renal function.
    Höffler D; Schäfer I; Koeppe P; Sörgel F
    Arzneimittelforschung; 1988 May; 38(5):739-43. PubMed ID: 3166377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.